| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |